insights_auto
Prečo akcie 0QF stúpli 12,85%?
Preskúmať podrobnejšiechevron_right
0QF:FRA
Moderna Inc
197,54 €
arrow_upward
+12,85%(+22,50) 1 d.
9. 10., 22:00:00 GMT+2 · EUR
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre 0QF…
Otvoriť
174,60 €
Vysoká
200,00 €
Nízka
174,48 €
Trh. kap.
89,83 mld.
Priem. obj.
1,54 tis.
Objem
3,36 tis.
Max. za 52 týž.
200,00 €
Min. za 52 týž.
19,26 €
Počet zamestnancov
5 tis.
Otvoriť
174,60 €
Vysoká
200,00 €
Nízka
174,48 €
Trh. kap.
89,83 mld.
Priem. obj.
1,54 tis.
Objem
3,36 tis.
Max. za 52 týž.
200,00 €
Min. za 52 týž.
19,26 €
Počet zamestnancov
5 tis.
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
AD HOC NEWS
·
pred 42 minútami
Moderna stock trades 0.10 percent below its Xetra close of EUR 200.98 in weekend trading
MarketBeat
·
pred 57 minútami
11,652 Shares of Moderna, Inc. $MRNA Acquired by Gallagher Capital Advisors LLC
NAI500
·
pred 2 hodinami
Moderna Stock Soars as New Cancer Research Initiative Ignites Market Enthusiasm
The Globe and Mail
·
pred 12 hodinami
This Stock Is Up More than 560% This Year, but It Could Drop by 38%, According to Wall Street
Profil
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.
In May 2026, Time ranked Moderna first in their list of the World's Most Impactful Companies. Wikipedia
Informácie o subjekte Moderna Inc
Generálny riaditeľStéphane Bancel
Zamestnanci4,7 tis.
Dátum založeniasep 2010
Hlavné sídlo-
Odvetvie-